Is abnormal brain hyperactivity an early sign of Alzheimer disease?

Research led by former PhD student Nick Corriveau-Lecavalier and Sylvie Belleville, laboratory director at the Institut universitaire de gériatrie de Montréal and professor in the Department of Psychology at Université de Montréal, has shown that abnormal hyperactivation in certain areas of the brain, including the hippocampus and parietal lobe, may constitute an early sign of Alzheimer disease in at-risk individuals. Indeed, brain hyperactivity combined with genetic and cognitive tests could become a biomarker to pinpoint the disease several years before the first clinical signs, such as difficulties with memory, judgment and speech, ever appear. (to know more …)

The CIMA-Q Scientific Event / 2021 edition

For the 2021 edition of our annual scientific event, CIMA-Q invites you to attend, virtually on 2 consecutive mornings, June 1st and 2nd 2021, the presentations of members of our consortium of researchers. Nine CIMA-Q members will present the results of their work related to the use of clinical, neuropsychological or neuroimaging data, and biomaterial from the CIMA-Q Bank. In addition, we will have the pleasure and the privilege of welcoming as guest speakers * Dr Gillian Einstein, University of Toronto and Dr Cherryl Wellington, University of British Columbia, who will present their recent work (…learn more)